Search for: "MYLAN LABORATORIES LIMITED" Results 41 - 60 of 94
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Aug 2011, 12:33 am by Marie Louise
Intema Limited (Docket Report) US: Is claim construction the key to patent-eligibility of isolated DNA? [read post]
21 Oct 2014, 12:00 am
The author is occasional and much-appreciated guest contributor Suleman Ali (Holly IP), who writes as follows:Teva UK Limited & Teva Pharmaceuticals Limited v Leo Pharma A/S & Leo Laboratories Limited[2014] EWHC 3096 (Pat) is a decision by Mr Justice Birss in the Patents Court, England and Wales. [read post]
8 Dec 2010, 2:20 am by Marie Louise
(America-Israel Patent Law) Ziagen (Abacavir) – US: Mylan’s Matrix receives tentative FDA approval under PEPFAR for Abacavir Sulfate tablets, 60 mg (SmartBrief) [read post]
1 Apr 2013, 8:29 am by Gene Quinn
.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Lupin Pharmaceuticals, USA, Inc.; Apotex Corp.; and Apotex, Inc. in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent. [read post]
25 Nov 2009, 12:00 pm
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/   Highlights this week included: Ecuador to define its compulsory licence legislation (IP Watch) (Patently-O) Tavanic (Levofloxacin) – UK: Supreme Court refuses permission to appeal in Generics (UK) Ltd v Daiichi Pharmaceuticals (The SPC Blog) (JIPLP)   General Nil: The value of patents in a major crisis such as an influenza pandemic – Paper by… [read post]
3 Aug 2011, 3:31 am by Marie Louise
422/10 Georgetown University v Comptroller-General of Patents, Designs and Trade Marks (The SPC Blog) France: Limitation of the French designation of a European patent: before which office? [read post]
10 Nov 2010, 1:11 am by Kelly
Highlights this week included: US government intervenes in patentability of genes – AMP v USPTO (Patent Baristas) (Holman’s Biotech IP Blog) (Intellectual Property Law Blog) (Inovia) (BlawgIT) (IP Osgoode) Temodar (Temozolomide) – US: CAFC limits prosecution laches defense: Cancer Research Technology v Barr Laboratories (Inventive Step) (IPBiz) (Patently-O) (SmartBrief) Italian antitrust authority opens preliminary investigation into whether Pfizer subsidiary… [read post]
20 May 2009, 5:18 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Patent Baristas) (Ars Technica) (Patently-O) (IP Watchdog) (The Prior Art) (Patent Docs) (Patents4Life) Omnicef (Cefdinir) - US: CAFC rules en banc:… [read post]
17 Aug 2020, 8:37 am by Rebecca Tushnet
Again as alleged: At that time, defendant manufacturers’ products violated three of those factors: (1) their prescription pet food included indications of disease claims on the labels; (2) the distribution of promotional materials with disease claims were not limited to veterinary professionals; (3) they electronically disseminated promotional materials with disease claims to consumers on the internet. [read post]
27 Aug 2011, 7:55 pm
Unigene Laboratories v. [read post]
1 Sep 2009, 4:39 am
In April, 2008, the FDA announced a recall of the drug Digitek® (Digoxin) distributed by Mylan Bertek Pharmaceuticals, Inc. and UDL Laboratories, Inc. [read post]
14 Nov 2016, 9:16 am by Dennis Crouch
Watson Laboratories, Inc., No. 16-493 (pre-AIA, do secret sales count as prior art?) [read post]